Sitagliptin vs glipizide
FBG (mmol/L) · people with diabetes and CKD
1 finding from 1 review
- Insulin and glucose‐lowering agents for treating people with diabetes and chronic kidney disease 2018 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 397 participantsLow